Physician profile
Susan A Scott
NPI 1457497604
$13,533.22
in general payments reported to CMS, 2019-2025
54 companies · $5,194 in 2025
The $5,194 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,640 · 2022: $2,267 · 2023: $2,355 · 2024: $1,079 · 2025: $5,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,754 · Travel and Lodging: $1,171 · Education: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,754.45 |
| Travel and Lodging | $1,171.25 |
| Education | $701.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,582.28 | 2022-2025 | Inspire |
| Noctrix Health, INC. | $2,423.87 | 2025 | Nidra |
| Jazz Pharmaceuticals INC. | $1,536.99 | 2021-2025 | |
| Abbvie INC. | $1,516.99 | 2021-2023 | |
| Harmony Biosciences LLC | $721.45 | 2021-2025 | Wakix |
| Ucb, INC. | $655.91 | 2021-2023 | Briviact, Nayzilam |
| Novartis Pharmaceuticals Corporation | $401.87 | 2021-2023 | |
| Avadel Cns Pharmaceuticals, LLC | $315.61 | 2023-2025 | Lumryz |
| Eisai INC. | $263.98 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $218.07 | 2021 | |
| Acorda Therapeutics, INC | $187.59 | 2022-2023 | Inbrija, Ampyra |
| Biogen, INC. | $179.25 | 2021-2023 | Vumerity |
| Genzyme Corporation | $150.88 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $128.84 | 2022 | |
| Idorsia Pharmaceuticals US INC | $127.03 | 2023 | Quviviq |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.